Compare · MDLN vs NEPH
MDLN vs NEPH
Side-by-side comparison of Medline Inc. (MDLN) and Nephros Inc. (NEPH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and NEPH operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $46.86B, about 1022.4x NEPH ($45.8M).
- Over the past year, MDLN is down 12.5% and NEPH is up 7.0% - NEPH leads by 19.6 points.
- MDLN has been more active in the news (12 items in the past 4 weeks vs 5 for NEPH).
- MDLN has more recent analyst coverage (25 ratings vs 1 for NEPH).
- Company
- Medline Inc.
- Nephros Inc.
- Price
- $35.64+2.77%
- $4.42+7.02%
- Market cap
- $46.86B
- $45.8M
- 1M return
- -10.28%
- +21.60%
- 1Y return
- -12.54%
- +7.02%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 12
- 5
- Recent ratings
- 25
- 1
Nephros Inc.
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company operates through three segments: Water Filtration, Pathogen Detection, and Renal Products. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company develops and sells water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. Nephros, Inc. was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Latest MDLN
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.
Latest NEPH
- Large owner Wexford Capital Lp exercised 812 shares at a strike of $3.60 (SEC Form 4)
- SEC Form 10-Q filed by Nephros Inc.
- Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026
- Nephros Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- Nephros Schedules Second Quarter 2026 Financial Results Conference Call
- Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
- Northland Capital initiated coverage on Nephros with a new price target
- Nephros Announces Inclusion in the Russell Microcap® Index
- Nephros to Host Virtual Investor Event: "Beyond Filtration: The Nephros Model in Action"
- Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water